Sana Alajmovic CEO Sigrid Therapeutics

Wed, Aug 16, 2023 08:30 CET

Medium resolution

Original resolution

Subscribe

Related Releases

Sigrid Therapeutics announces appointment of distinguished Professor Iain Chapple to Scientific Advisory Board Tue, May 09, 2023 08:30 CET

Sigrid Therapeutics unveils SiPore® plaque blocker at IDS 2023 Tue, Mar 14, 2023 08:30 CET

Sigrid Therapeutics reports positive results from consumer blood sugar management trial using SiPore® formulated dietary supplements in pre-diabetics, type 2 diabetics, and obese individuals Wed, Mar 08, 2023 08:30 CET